Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

The average repair cost for the UK’s ten most popular used cars in 2024 increased by 20”, compared to 2023. That’s the key ...

Summit Therapeutics Inc.’s SMMT share price has surged by 5.60%, which has investors questioning if this is right time to sell.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), SAP SE (SAP) ...

Summit Therapeutics sank -5.8% this morning, compared to the S&P 500's day change of -0.0%. Today's losers may turn out to be ...

As of April 15, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

A colour that was once an incredibly popular sight could vanish from new models as soon as 2026 as over 27% of Brits choose the same shade for their car.

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Summit Therapeutics (SMMT – Research Report) today. The company’s ...

We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look at where Summit Therapeutics Inc. (NASDAQ:SMMT) stands against other ...

Summit Therapeutics (NasdaqGM:SMMT) recently experienced an executive shakeup with the appointment of Robert LaCaze as Chief Commercial Officer, which could have influenced its stock price increase of ...

Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution.